Form 4 for CAMP Camp4 Therapeutics Corp
Accepted 2026-08-05 17:07:21 ET · period of report 2026-08-03 · accession 0001628280-26-053505 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 17:07 | 2026-08-03 | CAMP | Mandel-Brehm Josh | CEO, Dir | P - Purchase | $1.65 | +6,551 | 285.0K | +2% | +$10.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-03 | P | A | 6,551 | $1.65 | 284,968 | D | — | — | (F1) On August 3, 2026, the reporting person acquired shares in the second closing of a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement, dated as of September 9, 2025, as amended on August 3, 2026, by and among the Issuer and certain institutional investors and certain directors, employees, and consultants, at a purchase price of $1.65 per share. |